420 related articles for article (PubMed ID: 17513921)
1. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
Wright TC
Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
[TBL] [Abstract][Full Text] [Related]
2. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam S; Franco EL; Ferenczy A
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
6. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
9. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in cervical screening and vaccination.
Crosbie EJ; Kitchener HC
Clin Sci (Lond); 2006 May; 110(5):543-52. PubMed ID: 16597323
[TBL] [Abstract][Full Text] [Related]
11. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
[TBL] [Abstract][Full Text] [Related]
12. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
13. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
16. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
17. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
18. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
[TBL] [Abstract][Full Text] [Related]
19. Role of human papilloma virus testing in cervical cancer prevention.
Fey MC; Beal MW
J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
[TBL] [Abstract][Full Text] [Related]
20. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM
Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
